Also, CPNE1 is significantly correlated with the tumor stage, Gleason score and recurrence-free survival of prostate cancer and is positively correlated with expression of TRAF2 as a prognostic marker in prostate cancer [17]. This evidence concerns the gene TRAF2 and prostate carcinoma.